Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 6;12(5):753.
doi: 10.3390/jpm12050753.

The Role of SNHG15 in the Pathogenesis of Hepatocellular Carcinoma

Affiliations
Review

The Role of SNHG15 in the Pathogenesis of Hepatocellular Carcinoma

Christos Damaskos et al. J Pers Med. .

Abstract

Long non-coding RNAs (lncRNAs) are transcripts of more than 200 nucleotides which cannot be translated into proteins. Small nucleolar RNA host gene 15 (SNHG15) is a lncRNA whose dysregulation has been found to have an important impact on carcinogenesis and affect the prognosis of cancer patients in various cancer types. Hepatocellular carcinoma (HCC) is one of the most common cancers with a poor long-term prognosis, while the best prognostic factor of the disease is its early diagnosis and surgery. Consequently, the investigation of the mechanisms of hepatocarcinogenesis, as well as the discovery of efficient molecular markers and therapeutic targets are of great significance. An extensive literature search was performed in MEDLINE in order to identify clinical studies that tried to reveal the role of SNHG15 in HCC. We used keywords such as 'HCC', 'hepatocellular carcinoma', 'SNHG15' and 'clinical study'. Finally, we included four studies written in English, published during the period 2016-2021. It was revealed that SNHG15 is related to the appearance of HCC via different routes and its over-expression affects the overall survival of the patients. More assays are required in order to clarify the potential role of SNHG15 as a prognostic tool and therapeutic target in HCC.

Keywords: SNHG15; cancer; carcinoma; hepatocarcinogenesis; hepatocellular; lncRNA.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA flow diagram for the current article process.
Figure 2
Figure 2
Effects of SNHG15 on hepatocellular carcinoma.

References

    1. Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. Dimitroulis D., Damaskos C., Valsami S., Davakis S., Garmpis N., Spartalis E., Athanasiou A., Moris D., Sakellariou S., Kykalos S., et al. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. World J. Gastroenterol. 2017;23:5282–5294. doi: 10.3748/wjg.v23.i29.5282. - DOI - PMC - PubMed
    1. Zhu R.X., Seto W.K., Lai C.L., Yuen M.F. Epidemiology of hepatocellular carcinoma in the Asia-Pacific region. Gut Liver. 2016;10:332–339. doi: 10.5009/gnl15257. - DOI - PMC - PubMed
    1. Garmpis N., Damaskos C., Garmpi A., Georgakopoulou V.E., Sarantis P., Antoniou E.A., Karamouzis M.V., Nonni A., Schizas D., Diamantis E., et al. Histone deacetylase inhibitors in the treatment of hepatocellular carcinoma: Current evidence and future opportunities. J. Pers. Med. 2021;11:223. doi: 10.3390/jpm11030223. - DOI - PMC - PubMed
    1. El-Sherag H.B., Rudolph K.L. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–2576. doi: 10.1053/j.gastro.2007.04.061. - DOI - PubMed

LinkOut - more resources